All Stories

  1. GIP Receptor Antagonists in the Pharmacotherapy of Obesity: Physiologic, Genetic, and Clinical Rationale

    Article • Diabetes, June 2025, American Diabetes Association

    prof Jens Juul Holst

  2. Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture

    Article • Diabetes, October 2021, American Diabetes Association

    prof Jens Juul Holst

  3. Short-chain fatty acids and regulation of pancreatic endocrine secretion in mice

    Article • Islets, August 2019, Taylor & Francis

    prof Jens Juul Holst

  4. Pros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes

    Article • Expert Review of Endocrinology & Metabolism, June 2019, Taylor & Francis

    prof Jens Juul Holst

  5. Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

    Article • Scandinavian Journal of Gastroenterology, November 2018, Taylor & Francis

    Jens F. Rehfeld, prof Jens Juul Holst

  6. Comparison of Glycomacropeptide with Phenylalanine Free-Synthetic Amino Acids in Test Meals to PKU Patients: No Significant Differences in Biomarkers, Including Plasma Phe Levels

    Article • Journal of Nutrition and Metabolism, January 2018, Hindawi Publishing Corporation

    Jens F. Rehfeld, prof Jens Juul Holst

  7. Single-Dose Metformin Enhances Bile Acid–Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2017, Endocrine Society

    Dr Filip K Knop, Jens F. Rehfeld, prof Jens Juul Holst

  8. The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2017, Endocrine Society

    prof Jens Juul Holst

  9. Insulin and Glucagon: Partners for Life

    Article • Endocrinology, January 2017, Endocrine Society

    prof Jens Juul Holst

  10. Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells

    Article • Journal of Molecular Endocrinology, January 2016, Bioscientifica

    prof Jens Juul Holst

  11. Heterogeneity of glucagonomas due to differential processing of proglucagon-derived peptides

    Article • Endocrinology Diabetes and Metabolism Case Reports, December 2015, Bioscientifica

    prof Jens Juul Holst

  12. IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

    Article • Journal of Diabetes Science and Technology, October 2015, SAGE Publications

    prof Jens Juul Holst

  13. The anorexic hormone Peptide YY3-36is rapidly metabolized to inactive Peptide YY3-34in vivo

    Article • Physiological Reports, July 2015, Wiley

    prof Jens Juul Holst

  14. Stability of glucagon-like peptide 1 and glucagon in human plasma

    Article • Endocrine Connections, March 2015, Bioscientifica

    prof Jens Juul Holst

  15. The VGF-Derived Neuropeptide TLQP-21 Shows No Impact on Hormone Secretion in the Isolated Perfused Rat Pancreas

    Article • Hormone and Metabolic Research, January 2015, Thieme Publishing Group

    prof Jens Juul Holst

  16. Therapies for inter-relating diabetes and obesity – GLP-1 and obesity

    Article • Expert Opinion on Pharmacotherapy, September 2014, Informa Healthcare

    prof Jens Juul Holst

  17. Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

    Article • January 2014, Bioscientifica

    prof Jens Juul Holst